TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23434222

Group type: EXPERIMENTAL
Intervention: New fertilization method with decreasing number of spermatozoa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard fertilization method)
Number of subjects: 0
Study: 21180238

Group type: EXPERIMENTAL
Intervention: 400 meters walking test (400mWT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 6 minutes walking test (6MWT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cycloergometer exercise stress test
Number of subjects: 20
Study: 18389313

Group type: EXPERIMENTAL
Intervention: Velocity mechanical port applier fixation (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Titanium suture-fixation port (group B)
Number of subjects: 50
Study: 16446318

Group type: EXPERIMENTAL
Intervention: High-dose alkylating chemotherapy (cyclophosphamide, thiotepa and carboplatin)
Number of subjects: 621

Group type: COMPARATOR
Intervention: Standard treatment (FEC followed by radiation therapy and tamoxifen)
Number of subjects: 621
Study: 12582945

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (60 mg four times daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (25 mg four times daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine
Number of subjects: 8
Study: 11432680

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single preoperative dose)
Number of subjects: 808

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 808
Study: 9410681

Group type: EXPERIMENTAL
Intervention: Open access laparoscopic surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Veress needle technique
Number of subjects: 50
Study: 8415806

Group type: EXPERIMENTAL
Intervention: Evening primrose oil (4 g), sardine oil (2.4 g), vitamin E (200 mg) for 4 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Evening primrose oil and fish oil treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no oils)
Number of subjects: 18
Study: 2877480

Group type: EXPERIMENTAL
Intervention: Active treatment for hypertension
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study: 30772789

Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 599
Study: 28282796

Group type: EXPERIMENTAL
Intervention: Low level continuous heat (LLCH)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Low level continuous heat with Ibuprofen (LLCH + IP)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham LLCH with sham Ibuprofen
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study: 25075645

Group type: EXPERIMENTAL
Intervention: Topical cream 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical cream 2
Number of subjects: 0
Study: 23356673

Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter (OPC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Inpatient vaginal PGE2 (IP)
Number of subjects: 101
Study: 21610557

Group type: EXPERIMENTAL
Intervention: Low-volume ultrasound-guided ankle block (16 mL ropivacaine 0.5%)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional-volume surface landmark technique (30 mL ropivacaine 0.5%)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low-volume ultrasound-guided ankle block
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional-volume surface landmark technique
Number of subjects: 72
Study: 18496477

Group type: EXPERIMENTAL
Intervention: Dronabinol (synthetic delta9-THC)
Number of subjects: 1
Study: 16680438

Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty without patellar resurfacing
Number of subjects: 111
Study: 12803865

Group type: COMPARATOR
Intervention: Chloroquine (CQ) alone (30 mg/kg base given over 3 days)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Chloroquine plus ketotifen (CQK) (0.25 mg at presentation followed by 0.125 mg/kg every 8 h for 5 days)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Retreatment with CQK
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus pyrimethamine-sulfadoxine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Chloroquine (CQ) alone
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Chloroquine plus ketotifen (CQK)
Number of subjects: 145
Study: 11147611

Group type: EXPERIMENTAL
Intervention: Intensive screening with chest X-rays and sputum cytology tests every 4 months for 6 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group advised to undergo chest X-rays and sputum cytology tests yearly
Number of subjects: 0
Study: 8851579

Group type: EXPERIMENTAL
Intervention: 20% fat emulsion formulation (Intralipid; 20% IL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5% dextrose (glucose) (5% D) solution
Number of subjects: 16
Study: 1471513

Group type: EXPERIMENTAL
Intervention: Fracture reduction
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Preoperative radiographic signs (small head fragment, comminution of the calcar femorale, varus angulation of the head)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Negative predictive signs
Number of subjects: 149
Study: 6720619

Group type: EXPERIMENTAL
Intervention: Calcium supplement (1 g/day for 8 days)
Number of subjects: 14
Study: 30267357

Group type: EXPERIMENTAL
Intervention: Local glucocorticoid (GC) injection combined with local anaesthetic
Number of subjects: 46

Group type: COMPARATOR
Intervention: Normal saline solution (placebo)
Number of subjects: 46
Study: 30272098

Group type: EXPERIMENTAL
Intervention: High-speed resistance exercise training (n=22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (balance and band stretching, n=23)
Number of subjects: 45
Study: 28082816

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCFM (low-dose)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus NCFM (high-dose)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 340
Study: 25257294

Group type: EXPERIMENTAL
Intervention: Context aware experiential sampling in social settings (pub, bar, club)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Current alcohol consumption
Number of subjects: 72
Study: 22859747

Group type: EXPERIMENTAL
Intervention: Vascular disease
Number of subjects: 837

Group type: COMPARATOR
Intervention: Standard survival analysis
Number of subjects: 837
Study: 20132649

Group type: EXPERIMENTAL
Intervention: Chewing gum (mint and fruit varieties)
Number of subjects: 133

Group type: COMPARATOR
Intervention: No chewing gum (baseline condition)
Number of subjects: 133
Study: 17322450

Group type: EXPERIMENTAL
Intervention: rhBMP-7
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no rhBMP-7)
Number of subjects: 40
Study: 16351593

Group type: EXPERIMENTAL
Intervention: Trandolapril and ultra filtration
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ultra filtration (control group)
Number of subjects: 80
Study: 11867886

Group type: EXPERIMENTAL
Intervention: Vitamin supplements (folic acid 2 mg, B(6) 25 mg, B(12) 500 mug)
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 8000
Study: 11210402

Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride (2.4 g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No sevelamer (control)
Number of subjects: 60
Study: 9743509

Group type: COMPARATOR
Intervention: β-blockers
Number of subjects: 3023
Study: 7949264

Group type: EXPERIMENTAL
Intervention: Intraoperative fibrin sealing (Group A, 43 subjects)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No fibrin sealing (Group B, 54 patients)
Number of subjects: 97
Study: 3109445

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vegetable oil (placebo)
Number of subjects: 36
Study: 29044532

Group type: EXPERIMENTAL
Intervention: Duct-to-mucosa technique
Number of subjects: 193

Group type: COMPARATOR
Intervention: Dunking technique
Number of subjects: 193
Study: 28446223

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT) programme included in social and emotional provision.
Number of subjects: 5700

Group type: COMPARATOR
Intervention: Normal school provision (control group).
Number of subjects: 5700
Study: 26181147

Group type: EXPERIMENTAL
Intervention: Group therapeutic exercises
Number of subjects: 2

Group type: COMPARATOR
Intervention: Physically inactive
Number of subjects: 2
Study: 23952805

Group type: EXPERIMENTAL
Intervention: iLarynx software
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 20
Study: 21062778

Group type: EXPERIMENTAL
Intervention: Single-point cardiac troponin I (cTnI) sampling at 24 or 48 hours
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Single-point cardiac troponin I (cTnI)
Number of subjects: 132
Study: 18430053

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day) for 4 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pravastatin (10 mg/day) for 4 months
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 36
Study: 16670247

Group type: EXPERIMENTAL
Intervention: 10 mg memantine twice a day
Number of subjects: 404

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 404
Study: 15030296

Group type: EXPERIMENTAL
Intervention: Combination therapy with ACE inhibitors or angiotensin II receptor antagonists and diuretics
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors or angiotensin II receptor antagonists alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diuretics alone
Number of subjects: 0
Study: 10663453

Group type: COMPARATOR
Intervention: Lariam (reference formulation)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Mephaquin 100 Lactab
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Eloquin-250
Number of subjects: 29
Study: 8644658

Group type: EXPERIMENTAL
Intervention: Prolonged balloon inflations (3 to 5 inflations of 3 to 5 minutes each; n = 149)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Standard balloon inflations (3 to 5 inflations < or = 1 minute each; n = 161)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 289
Study: 1586398

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 2182

Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 2182

Group type: COMPARATOR
Intervention: Stress management
Number of subjects: 2182

Group type: COMPARATOR
Intervention: Nutritional supplements (calcium, magnesium, potassium, fish oil)
Number of subjects: 2182
Study: 30796686

Group type: EXPERIMENTAL
Intervention: Single-balloon enteroscopy with a transparent cap
Number of subjects: 90

Group type: COMPARATOR
Intervention: Single-balloon enteroscopy without a transparent cap
Number of subjects: 90
Study: 29448886

Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 26

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 26
Study: 25754214

Group type: EXPERIMENTAL
Intervention: Synbiotics (Lactobacillus, Bifidobacterium, and fructo‐oligosaccharide)
Number of subjects: 220

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 220
Study: 24500432

Group type: EXPERIMENTAL
Intervention: HMB-FA
Number of subjects: 39

Group type: COMPARATOR
Intervention: CWI
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: HMB-FA-CWI
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo-CWI
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 22187126

Group type: EXPERIMENTAL
Intervention: Dose-dense sequential epirubicin 110 mg/m(2) and paclitaxel 250 mg/m(2)
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Concurrent epirubicin 83 mg/m(2) and paclitaxel 187 mg/m(2)
Number of subjects: 1121
Study: 20542391

Group type: EXPERIMENTAL
Intervention: 25 mg naltrexone
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 17394081

Group type: EXPERIMENTAL
Intervention: Calcium polycarbophil (3 g/day) plus bifidobacterium (3 g/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bifidobacterium (3 g/day)
Number of subjects: 21
Study: 16295151

Group type: EXPERIMENTAL
Intervention: Nutrition Education Aimed at Toddlers (NEAT) intervention, comprising four nutrition lessons and structured reinforcements over 6 months
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 135
Study: 12087454

Group type: EXPERIMENTAL
Intervention: Three cycles of cyclophosphamide, methotrexate and fluorouracil (CMF)
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Six cycles of cyclophosphamide, methotrexate and fluorouracil (CMF)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Three cycles of CMF for patients at least 40 years old with oestrogen-receptor-positive tumours
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Three cycles of CMF for women less than 40 years old
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Three cycles of CMF for women with oestrogen-receptor-negative tumours
Number of subjects: 1024
Study: 10215752

Group type: EXPERIMENTAL
Intervention: Subcutaneous lenograstim (0.5, 2, 5, or 10 microg kg(‐1))
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intravenous lenograstim (0.5, 2, 5, or 10 microg kg(‐1))
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Subcutaneous lenograstim (5 microg kg(‐1))
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intravenous lenograstim (5 microg kg(‐1))
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both routes of lenograstim
Number of subjects: 27
Study: 7891484

Group type: COMPARATOR
Intervention: D1 dissection
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: D2 dissection
Number of subjects: 711
Study: 2170718

Group type: EXPERIMENTAL
Intervention: 1.0 microgram dose group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.5 microgram dose group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 0.25 microgram dose group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study: 374162

Group type: EXPERIMENTAL
Intervention: Phyllocontin Continus tablets
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of Ventolin tablets and Phyllocontin tablets
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ventolin tablets
Number of subjects: 40
Study: 31318742

Group type: EXPERIMENTAL
Intervention: Self-reported Functional Independence Measure (care recipient self-reported)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Caregiver self-reported Functional Independence Measure
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Evaluator rated Functional Independence Measure
Number of subjects: 90

Group type: COMPARATOR
Intervention: Care recipient self-reported Functional Independence Measure
Number of subjects: 90
Study: 27803006

Group type: EXPERIMENTAL
Intervention: Buparlisib with paclitaxel
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo with paclitaxel
Number of subjects: 416
Study: 25525954

Group type: EXPERIMENTAL
Intervention: Eccentric overload training (EOT)
Number of subjects: 20
Study: 22374732

Group type: EXPERIMENTAL
Intervention: 12-week online support group intervention including moderated discussion forum and psycho-educational materials.
Number of subjects: 27

Group type: COMPARATOR
Intervention: Waitlist control condition.
Number of subjects: 27
Study: 21318564

Group type: EXPERIMENTAL
Intervention: D-cycloserine (250 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 19670959

Group type: EXPERIMENTAL
Intervention: Guided Care (GC)
Number of subjects: 904
Study: 17895576

Group type: EXPERIMENTAL
Intervention: Azelnidipine for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin C and E for 8 weeks
Number of subjects: 0
Study: 15121119

Group type: EXPERIMENTAL
Intervention: Local Anaesthesia (LA) CEA
Number of subjects: 176

Group type: COMPARATOR
Intervention: General Anaesthesia (GA) CEA
Number of subjects: 176
Study: 11219510

Group type: EXPERIMENTAL
Intervention: Genetic algorithm neural network assessment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Relative distance (Dr) assessment
Number of subjects: 20
Study: 9240864

Group type: EXPERIMENTAL
Intervention: Phase I and II trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase III trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethically impeccable study designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wide access to drugs
Number of subjects: 0
Study: 7894910

Group type: EXPERIMENTAL
Intervention: Citrate blood samples stored longer than 1 hour
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Citrate blood samples stored on the cold for 24 hours
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Citrate blood samples adapted to room temperature after cold storage
Number of subjects: 58
Study: 3473681

Group type: EXPERIMENTAL
Intervention: 1 + 5 DAT
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: 3 + 10 DAT
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Consolidation therapy (COAP or MAZE)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Conventional doses of ara‐C
Number of subjects: 1000
Study: 31634205

Group type: EXPERIMENTAL
Intervention: Maternal genetic variants as instruments (four independent variants)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulations of instrumental inequalities
Number of subjects: 0
Study: 29019878

Group type: EXPERIMENTAL
Intervention: Hybrid Surgery (HS)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 55
Study: 25172986

Group type: EXPERIMENTAL
Intervention: Combined intervention of information and communication (standard information about MRI scans and communication via intercom every 2 minutes)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined intervention of information and communication
Number of subjects: 33
Study: 23344474

Group type: EXPERIMENTAL
Intervention: Frequent nocturnal hemodialysis
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (three-times-per-week hemodialysis)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Frequent daily hemodialysis
Number of subjects: 146
Study: 22333201

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d) for 12 weeks
Number of subjects: 76
Study: 19480608

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 0
Study: 17301099

Group type: EXPERIMENTAL
Intervention: Sputum group (management strategy to minimise eosinophilic airway inflammation)
Number of subjects: 82

Group type: COMPARATOR
Intervention: BTS group (traditional guidelines)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Sputum group
Number of subjects: 82
Study: 15675647

Group type: EXPERIMENTAL
Intervention: Stimulus set in upper or lower display positions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus set in left, center, or right positions relative to response location
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response location relative to stimulus display and body midline
Number of subjects: 0
Study: 12577375

Group type: EXPERIMENTAL
Intervention: Ningxie Powder (NXP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: salicylazosulfapyridine (SASP)
Number of subjects: 63
Study: 9802618

Group type: EXPERIMENTAL
Intervention: Adjuvant irradiation
Number of subjects: 356

Group type: COMPARATOR
Intervention: No radiotherapy
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen therapy with no irradiation
Number of subjects: 356

Group type: COMPARATOR
Intervention: Adjuvant tamoxifen therapy with irradiation
Number of subjects: 356
Study: 7984295

Group type: EXPERIMENTAL
Intervention: Low-tryptophan (low-TRP) drink
Number of subjects: 12
Study: 2725871

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 29055130

Group type: EXPERIMENTAL
Intervention: Combined coasting and cabergoline
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cabergoline alone
Number of subjects: 300

Group type: COMPARATOR
Intervention: Coasting alone
Number of subjects: 300
Study: 28552806

Group type: EXPERIMENTAL
Intervention: Anti-Helicobacter pylori concomitant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Saccharomyces boulardii)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eradication therapy without probiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probiotic combination
Number of subjects: 0
Study: 26596011

Group type: EXPERIMENTAL
Intervention: Postaurical injection of methylprednisolone, 40 mg/2 d for 14 d, combined with Ginkgo dipyidamolum and Alprostadil.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral prednisone, 1 mg/kg/d for 3 d, if effective, prolonging for another 2 d, combined with Ginkgo dipyidamolum and Alprostadil.
Number of subjects: 80
Study: 24132980

Group type: EXPERIMENTAL
Intervention: High-fat equicaloric chocolate milkshake
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: High-sugar equicaloric chocolate milkshake
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Increasing sugar in low-fat milkshakes
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Increasing fat content in low-fat milkshakes
Number of subjects: 106

Group type: COMPARATOR
Intervention: Tasteless solution
Number of subjects: 106
Study: 21147857

Group type: EXPERIMENTAL
Intervention: Playing solitaire during lunch (distraction)
Number of subjects: 44

Group type: COMPARATOR
Intervention: No distraction during lunch (control)
Number of subjects: 44
Study: 18637053

Group type: EXPERIMENTAL
Intervention: Plasma Exchange (PE)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control
Number of subjects: 280
Study: 16549954

Group type: EXPERIMENTAL
Intervention: Drug group (heparin, abciximab, or thrombolytics)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No-drug group
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Drug group
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Drug group (collagen plug devices vs. suture-mediated devices)
Number of subjects: 108